Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Keratoconus, Unstable: early-phase trial registry
1 of 3 indexed Keratoconus, Unstable trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Keratoconus, Unstable: 3 US clinical trials tracked, 1 recruiting.
Keratoconus, Unstable is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Eye Specialists of Indiana, running 1 of these trials.
Enrollment posture brief
Registry condition keratoconus-unstable
OPEN 1 | RECR 33% | LATE 1 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Keratoconus, Unstable lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Keratoconus, Unstable on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Keratoconus, Unstable is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Pacific Clear Vision Institute
NCT03918408
Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study
Sight Medical Doctors P
NCT04168112
Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position
Eye Specialists of Indiana
NCT04213885
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Keratoconus, Unstable records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Keratoconus, Unstable trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Keratoconus, Unstable page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Keratoconus, Unstable trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eye Specialists of Indiana sponsors the most Keratoconus, Unstable trials on record, review their full trial history before evaluating a specific study. See Eye Specialists of Indiana's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Keratoconus, Unstable condition card totals 3 registered trials; most-linked intervention PXL 330 Platinum device/Riboflavin; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.